Startup Valuation by Stage: Seed to Series C

Why Valuation Changes by Stage

A startup's valuation method must match its maturity. Valuing a pre-seed company on revenue multiples is impossible (there is no revenue); valuing a Series C company on the Berkus Method is absurd (there is far too much data). Each stage has its own toolkit, its own typical range, and its own milestones that justify stepping up to the next valuation tier.

The ranges below are directional and vary enormously by market, geography, and sector — treat them as orientation, not quotes. For your specific estimate, use our Startup Valuation Calculator.

Pre-Seed: Idea to Prototype

Typical range: roughly $1M–$5M pre-money (wide variance by market). Method: Berkus or Scorecard — see our Berkus Method guide. At this stage, valuation is almost entirely about the team and the idea: repeat founders with prior exits command the top of the range; first-time founders with a slide deck sit at the bottom. The milestone that unlocks the next stage is a working product with early evidence of demand — a prototype plus pilot users or LOIs.

Seed: Product-Market Fit Search

Typical range: roughly $5M–$20M pre-money. Method: Scorecard plus early revenue multiples as traction appears. Seed investors price evidence of pull: growing waitlists, strong beta engagement, and the first dollars of revenue. The key milestone is repeatable early traction — the first $500k–$1M of ARR or its equivalent in engagement metrics. Companies that reach seed with real revenue and triple-digit growth can stretch well above the range; those still searching for fit cluster at the bottom.

Series A: Scaling What Works

Typical range: roughly $15M–$60M pre-money. Method: revenue multiples, growth-adjusted. Series A is the first round where valuation is primarily formulaic: ARR × multiple, with the multiple set by growth rate. The milestone that matters is repeatable go-to-market — you can articulate your CAC, payback, and sales motion, and the numbers support scaling spend. Our unit economics guide covers the metrics Series A investors scrutinize. A flat or declining growth rate at Series A compresses the multiple hard — this is where down rounds are born.

Series B and C: Efficient Scale

Typical range: Series B roughly $50M–$250M; Series C roughly $150M–$1B+. Method: public-market comparables, forward revenue multiples, and DCF cross-checks. At these stages, investors underwrite efficiency at scale: net revenue retention above 110%, a clear path to profitability, Rule of 40 discipline (see our Rule of 40 explainer), and credible $100M+ ARR trajectories. The milestone is durable market leadership in a large category — or at minimum, a convincing plan to get there.

Milestones That Unlock Step-Ups

• Pre-seed → Seed: working product + early demand signals (pilots, LOIs, waitlist, first revenue).
• Seed → Series A: $1M+ ARR (or equivalent traction) with strong growth and early signs of repeatable acquisition.
• Series A → B: $5M–$10M ARR, proven unit economics, and a sales motion that scales with spend.
• Series B → C: $20M–$50M+ ARR, efficient growth, expanding NRR, and a credible path to $100M ARR.

Missing a milestone does not just delay the round — it reprices it. Each stage's valuation assumes the previous stage's milestones were hit; arriving without them invites a flat or down round. Track your readiness with runway planning so you raise from strength, not desperation.

Conclusion

Valuation by stage is a ladder: qualitative methods at the bottom, revenue multiples in the middle, comparables and DCF at the top — with each rung's price set by the milestones beneath it. Know your stage's toolkit, hit the milestones that unlock the next rung, and raise before you need to. Start with How Startups Are Valued and the Startup Valuation Calculator.